Paper · 39697181
Cyclic di-AMP regulates genome stability and drug resistance in Mycobacterium through RecA-dependent and RecA-independent recombination.
Mudgal S and 8 others. PNAS Nexus, 2024. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cyclic di-AMP regulates genome stability and drug resistance in Mycobacterium through RecA-dependent and RecA-independent recombination. Papers, record 39697181. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39697181
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cyclic di-AMP regulates genome stability and drug resistance in Mycobacterium through RecA-dependent and RecA-independent recombination.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16,713,562 | A checkpoint protein that scans the chromosome for damage at the start of sporulation in Bacillus subtilis. | Cell | 2006 | https://conductscience.org/library/papers/16713562 | PubMed |
| 2 | 37,444,780 | Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. | Healthcare (Basel) | 2023 | https://conductscience.org/library/papers/37444780 | PubMed |
| 3 | 12,705,867 | DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. | Cell | 2003 | https://conductscience.org/library/papers/12705867 | PubMed |
| 4 | 29,873,124 | The second messenger cyclic di-AMP negatively regulates the expression of Mycobacterium smegmatis recA and attenuates DNA strand exchange through binding to the C-terminal motif of mycobacterial RecA proteins. | Mol Microbiol | 2018 | https://conductscience.org/library/papers/29873124 | PubMed |
| 5 | 15,620,655 | The small RNA IstR inhibits synthesis of an SOS-induced toxic peptide. | Curr Biol | 2004 | https://conductscience.org/library/papers/15620655 | PubMed |
| 6 | 34,715,302 | Cyclic di-AMP: Small molecule with big roles in bacteria. | Microb Pathog | 2021 | https://conductscience.org/library/papers/34715302 | PubMed |
| 7 | 26,525,148 | An Overview of the Molecular Mechanisms of Recombinational DNA Repair. | Cold Spring Harb Perspect Biol | 2015 | https://conductscience.org/library/papers/26525148 | PubMed |
| 8 | 16,107,138 | A molecular target for suppression of the evolution of antibiotic resistance: inhibition of the Escherichia coli RecA protein by N(6)-(1-naphthyl)-ADP. | J Med Chem | 2005 | https://conductscience.org/library/papers/16107138 | PubMed |
| 9 | 17,228,330 | Motoring along with the bacterial RecA protein. | Nat Rev Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17228330 | PubMed |
| 10 | 28,369,307 | Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives. | FEMS Microbiol Rev | 2017 | https://conductscience.org/library/papers/28369307 | PubMed |
1 to 10 of 76
See all 76 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,928,305 | Rhythmic-phasic c-di-AMP signaling: a new paradigm for bacterial growth synchronization governed by a pseudo-phosphodiesterase and modifiable diadenylate cyclase. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42928305 | PubMed |
| 41,988,085 | Structural and biochemical insights into the inhibition of Mycobacterium tuberculosis cyclic dinucleotide phosphodiesterase by a sulfur-modified cyclic dinucleotide analog. | RSC Chem Biol | 2026 | https://conductscience.org/library/papers/41988085 | PubMed |
| 41,837,629 | Mycobacterium tuberculosis as a model system. | J Bacteriol | 2026 | https://conductscience.org/library/papers/41837629 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39697181
GET https://conductscience.org/api/papers/v1/39697181/references?page=2